(Q36032349)

English

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials

scientific article

Statements

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials (English)
Andrew D Goodman
Francois Bethoux
Theodore R Brown
Randall T Schapiro
Lawrence N Marinucci
Herbert R Henney
Andrew R Blight
MS-F203, MS-F204, and Extension Study Investigators

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit